Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Mesenchymal Stem Cells in Refractory Multiple Sclerosis
NCT01895439Phase 2Completed
- Sponsor
- University of Jordan
- Start
- Oct 2012
- Primary completion
- Feb 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous mesenchymal stem cells in multiple sclerosis (MS), sponsored by University of Jordan. Started Oct 2012; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01895439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01895439.